ICICI Bank may slide after weak Q4 result

ICICI Bank's net profit dropped 49.62% to Rs 1020 crore on 20.24% rise in total income to Rs 19942.97 crore in Q4 March 2018 over Q4 March 2017. The announcement was made after market hours yesterday, 7 May 2018.

Pfizer's net profit surged 53.6% to Rs 104.51 crore on 18.06% rise in total income to Rs 551.18 crore in Q4 March 2018 over Q4 March 2017. The announcement was made after market hours yesterday, 7 May 2018.

Lupin announced that it has received final approval for its Clobetasol Propionate Ointment USP, 0.05% from the United States Food and Drug Administration (FDA) to market a generic version of Fougera Pharmaceuticals Inc.'s Temovate Ointment, 0.05%. Clobetasol Propionate Ointment USP, 0.05% had annual sales of approximately 120 million in the US (IQVIA MAT January 2018). The announcement was made after market hours yesterday, 7 May 2018.

Tata Metaliks said that there is no production at Kharagpur plant due to disruption of work by contractors' workers and service providers by not reporting to work and the same is currently continuing. The company is engaged in discussion with the representatives of the contractors' workers, facilitated by the representatives of government for resumption of work. The date of resumption of business operation will be intimated in due course. The announcement was made after market hours yesterday, 7 May 2018.

Unichem Laboratories announced that it has received ANDA approval from United States Food and Drug Administration (USFDA) for Valsartan Tablets USP, 40 mg, 80 mg, 160 mg and 320 mg, which are therapeutically equivalent to DIOVANB (Valsartan) tablets, 40 mg, 80 mg, 160 mg and 320 mg of Novartis Pharmaceuticals Corp. This product will be commercialized from Unichem's Ghaziabad plant. The announcement was made after market hours yesterday, 7 May 2018.

Powered by Capital Market - Live News